Insider Selling: United Therapeutics (NASDAQ:UTHR) CEO Sells 4,000 Shares of Stock

Insider Selling: United Therapeutics (NASDAQ:UTHR) CEO Sells 4,000 Shares of Stock

United Therapeutics Corporation (NASDAQ:UTHR - Get Free Report) CEO Martine Rothblatt sold 4,000 shares of United Therapeutics stock in a transaction dated Friday, September 26th. The stock was sold at an average price of $428.22, for a total value of $1,712,880.00. Following the completion of the sale, the chief executive officer directly owned 130 shares in the company, valued at $55,668.60. This trade represents a 96.85% decrease in their own…